Načítá se...
Off‐label prescriptions of drugs used for the treatment of Crohn’s disease or ulcerative colitis
BACKGROUND: Off‐label prescribing is encountered across various fields of medicine and creates alternative treatment options, but is associated with unknown safety risks. The use of off‐label drugs for the treatment of patients with inflammatory bowel diseases (IBD) has not been characterised before...
Uloženo v:
| Vydáno v: | Aliment Pharmacol Ther |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
John Wiley and Sons Inc.
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6593662/ https://ncbi.nlm.nih.gov/pubmed/30908719 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/apt.15229 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|